Get the Stockscreener App
1.51
6.21%
-0.10
Cardlytics Inc stock is traded at $1.51, with a volume of 1.37M.
It is down -6.21% in the last 24 hours and down -29.93% over the past month.
Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K. and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.
See More
Previous Close:
$1.61
Open:
$1.6
24h Volume:
1.37M
Relative Volume:
1.38
Market Cap:
$76.70M
Revenue:
$278.30M
Net Income/Loss:
$-189.30M
P/E Ratio:
-0.3912
EPS:
-3.86
Net Cash Flow:
$-28.12M
1W Performance:
+0.67%
1M Performance:
-29.93%
6M Performance:
-61.08%
1Y Performance:
-86.97%
1-Day Range:
$1.49
$1.69
1-Week Range:
$1.39
$1.6994
52-Week Range:
$1.22
$15.89
Cardlytics Inc Stock (CDLX) Company Profile
Name
Cardlytics Inc
Sector
Industry
Phone
888-798-5802
Address
675 PONCE DE LEON AVENUE, NE, ATLANTA, GA
Compare CDLX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDLX
Cardlytics Inc
|
1.51 | 76.70M | 278.30M | -189.30M | -28.12M | -3.86 |
|
OMC
Omnicom Group Inc
|
74.92 | 14.12B | 15.43B | 1.37B | 1.50B | 7.32 |
|
IPG
Interpublic Group Of Cos Inc
|
24.56 | 9.15B | 10.86B | 808.20M | 922.50M | 2.12 |
|
WPP
Wpp Plc Adr
|
37.08 | 7.59B | 18.59B | 256.66M | 1.13B | 1.1736 |
|
CRTO
Criteo S A Adr
|
34.90 | 1.61B | 1.96B | 102.18M | 144.20M | 1.72 |
|
MGNI
Magnite Inc
|
12.38 | 1.56B | 661.13M | 17.29M | 156.88M | 0.06 |
Cardlytics Inc Stock (CDLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-11-24 | Initiated | Evercore ISI | In-line |
| Aug-16-24 | Downgrade | Northland Capital | Outperform → Market Perform |
| Aug-15-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Aug-08-24 | Downgrade | Craig Hallum | Buy → Hold |
| Aug-08-24 | Downgrade | Lake Street | Buy → Hold |
| Aug-08-24 | Downgrade | Needham | Buy → Hold |
| Jun-20-24 | Resumed | BofA Securities | Neutral |
| Jun-18-24 | Initiated | Northland Capital | Outperform |
| Mar-15-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-29-23 | Initiated | Lake Street | Buy |
| Sep-08-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jul-14-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-13-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-12-22 | Downgrade | Craig Hallum | Buy → Hold |
| Apr-05-22 | Resumed | Wells Fargo | Overweight |
| Jun-18-21 | Initiated | Needham | Buy |
| Apr-15-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Apr-14-21 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-05-21 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-14-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Aug-28-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-21-20 | Downgrade | BofA/Merrill | Buy → Underperform |
| Mar-04-20 | Downgrade | Craig Hallum | Buy → Hold |
| Jan-15-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Dec-02-19 | Initiated | Craig Hallum | Buy |
| Nov-14-19 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-09-19 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jul-24-19 | Reiterated | BofA/Merrill | Buy |
| Jul-01-19 | Initiated | William Blair | Outperform |
| Jan-15-19 | Upgrade | BofA/Merrill | Neutral → Buy |
View All
Cardlytics Inc Stock (CDLX) Latest News
Mirabella Financial Services LLP Takes Position in Cardlytics, Inc. (NASDAQ:CDLX) - MarketBeat
Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - 01net
Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | CDLX Stock News - GuruFocus
Cardlytics, Inc. (NASDAQ:CDLX) Stake Boosted by RBF Capital LLC - MarketBeat
Cardlytics Announces Timing of Its First Quarter 2025 Earnings Release - 01net
Cardlytics chief legal officer sells $458 in stock By Investing.com - Investing.com Nigeria
Cardlytics chief legal officer sells $458 in stock - Investing.com Australia
Investigation announced for Long-Term Investors who hold - openPR.com
Do investors need to be concerned about Cardlytics Inc (CDLX)? - uspostnews.com
Understanding the Risks of Investing in Cardlytics Inc (CDLX) - knoxdaily.com
Cardlytics (NASDAQ:CDLX) and Cloudastructure (NASDAQ:CSAI) Head-To-Head Review - Defense World
Cardlytics, Inc. (NASDAQ:CDLX) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Brokerages Set Cardlytics, Inc. (NASDAQ:CDLX) PT at $6.42 - Defense World
LPL Financial LLC Sells 25,467 Shares of Cardlytics, Inc. (NASDAQ:CDLX) - Defense World
Rangeley Capital LLC Buys Shares of 320,000 Cardlytics, Inc. (NASDAQ:CDLX) - MarketBeat
Why Investors Shouldn't Be Surprised By Cardlytics, Inc.'s (NASDAQ:CDLX) 30% Share Price Plunge - simplywall.st
Cardlytics CFO Alexis DeSieno sells $14,444 worth of stock - Investing.com Australia
Cardlytics stock hits 52-week low at $1.73 amid sharp decline - Investing.com Australia
Cardlytics CEO Amit Gupta sells $13,259 in stock - Investing.com Australia
Cardlytics CFO Alexis DeSieno sells $14,444 worth of stock By Investing.com - Investing.com Canada
Cardlytics stock hits 52-week low at $1.73 amid sharp decline By Investing.com - Investing.com South Africa
Cardlytics CEO Amit Gupta sells $13,259 in stock By Investing.com - Investing.com Canada
Cardlytics Executives Conduct Share Sales - TradingView
16,729 Shares in Cardlytics, Inc. (NASDAQ:CDLX) Purchased by Virtu Financial LLC - Defense World
Cardlytics, Inc. (NASDAQ:CDLX) Stock Holdings Increased by Charles Schwab Investment Management Inc. - Defense World
Payfare and Cardlytics Partner to Launch Cash Back Rewards Program - FinTech Futures
Cardlytics hooks Wells Fargo as partner - FinTech Futures
Cardlytics, Inc. (NASDAQ:CDLX) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Cardlytics, Inc. Class Action: Levi & Korsinsky Reminds Cardlytics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025CDLX - PR Newswire
Brokerages Set Cardlytics, Inc. (NASDAQ:CDLX) Price Target at $6.42 - Defense World
Cardlytics reports Q4 adjusted EPS 0c, consensus (20c) - MSN
Class Action Filed Against Cardlytics, Inc. (CDLX)March 25, 2025 Deadline to Join – Contact Levi & Korsinsky - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against ESSA, Cardlytics, Novo Nordisk, and Crocs and Encourages Investors to Contact the Firm - TradingView
Lost Money on Cardlytics, Inc.(CDLX)? Join Class Action Suit Seeking RecoveryContact The Gross Law Firm - PR Newswire
Cardlytics, Inc. (NASDAQ: CDLX) Investor Alert: Deadline in Lawsuit on March 25, 2025 - openPR.com
March 2025 Penny Stocks Worth Watching - Simply Wall St
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in Cardlytics Lawsuit – CDLX - GlobeNewswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in ... - Bluefield Daily Telegraph
Contact Levi & Korsinsky by March 25, 2025 Deadline to Join Class Action Against Cardlytics, Inc.(CDLX) - PR Newswire
The Gross Law Firm Reminds Cardlytics, Inc. Investors of - GlobeNewswire
The Gross Law Firm Reminds Cardlytics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 – CDLX - TradingView
Cardlytics Inc Stock (CDLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.29%
0.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):